PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
76 hedge funds and large institutions have $68.8M invested in Paratek Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 29 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+4
Holders Change %
+5.56%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
19
Reduced
29
Closed
8
Calls
$108K
Puts
$17K
Net Calls
+$91K
Net Calls Change
-$161K
Top Buyers
| 1 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
+$26.3M |
| 2 |
Millennium Management
New York
|
+$513K |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$504K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$419K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$302K |
Top Sellers
| 1 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
-$1.29M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$764K |
| 3 |
Two Sigma Investments
New York
|
-$531K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$448K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$155K |
